Hypercholesterolemia induces side-specific phenotypic changes and peroxisome proliferator-activated receptor-gamma

Marie A Guerraty1, Gregory R Grant, John W Karanian

  • 1Institute for Medicine and Engineering, University of Pennsylvania, Philadelphia 19104, USA.

Insights

The aortic side of aortic valves, prone to sclerosis, shows a protective endothelial response to high cholesterol. This protective phenotype, identified through gene expression, persists over time in a swine model.

Area of Science:

  • Cardiovascular Biology
  • Endothelial Cell Biology
  • Aortic Valve Disease

Background:

  • Healthy aortic valve endothelium exhibits distinct phenotypes on aortic and ventricular sides.
  • The aortic side, susceptible to sclerosis, shows balanced propathological and protective pathways.
  • Understanding endothelial phenotype balance is key to early aortic valve sclerosis detection.

Purpose of the Study:

  • To investigate side-specific endothelial gene expression in early aortic valve sclerosis.
  • To determine the endothelial phenotype response to hypercholesterolemia in a large animal model.

Main Methods:

  • Adult male swine were fed hypercholesterolemic or normal diets for 2 weeks and 6 months.
  • Transcript profiling analyzed differential gene expression in aortic and ventricular valve endothelial populations.
  • Pathway analysis identified key biological pathways involved in the endothelial response.

Main Results:

  • Hypercholesterolemia induced lipid insudation on the aortic side of leaflets.
  • The aortic side showed significantly higher differential gene expression (1,325 genes) compared to the ventricular side (87 genes) after 2 weeks.
  • Pathway analysis revealed differential expression of protective pathways (e.g., PPAR-gamma, NF-kappaB) on the susceptible aortic side, confirmed at the protein level.

Conclusions:

  • Aortic valve endothelium on the pathosusceptible side is responsive to hypercholesterolemia.
  • Transcriptional profiles indicate an induced and persistent protective endothelial phenotype on the side prone to aortic valve sclerosis.
Abstract

Related Concept Videos

Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...